The branched-chain amino acid (BCAA) pathway and high levels of BCAA transaminase 1 (BCAT1) have recently been associated with aggressiveness in several cancer entities. However, the mechanistic role of BCAT1 in this process remains largely uncertain. Here, by performing high-resolution proteomic analysis of human acute myeloid leukaemia (AML) stem-cell and non-stem-cell populations, we find the BCAA pathway enriched and BCAT1 protein and transcripts overexpressed in leukaemia stem cells. We show that BCAT1, which transfers α-amino groups from BCAAs to α-ketoglutarate (αKG), is a critical regulator of intracellular αKG homeostasis. Further to its role in the tricarboxylic acid cycle, αKG is an essential cofactor for αKG-dependent dioxygenases such as Egl-9 family hypoxia inducible factor 1 (EGLN1) and the ten-eleven translocation (TET) family of DNA demethylases. Knockdown of BCAT1 in leukaemia cells caused accumulation of αKG, leading to EGLN1-mediated HIF1α protein degradation. This resulted in a growth and survival defect and abrogated leukaemia-initiating potential. By contrast, overexpression of BCAT1 in leukaemia cells decreased intracellular αKG levels and caused DNA hypermethylation through altered TET activity. AML with high levels of BCAT1 (BCAT1) displayed a DNA hypermethylation phenotype similar to cases carrying a mutant isocitrate dehydrogenase (IDH), in which TET2 is inhibited by the oncometabolite 2-hydroxyglutarate. High levels of BCAT1 strongly correlate with shorter overall survival in IDHTET2, but not IDH or TET2 AML. Gene sets characteristic for IDH AML were enriched in samples from patients with an IDHTET2BCAT1 status. BCAT1 AML showed robust enrichment for leukaemia stem-cell signatures, and paired sample analysis showed a significant increase in BCAT1 levels upon disease relapse. In summary, by limiting intracellular αKG, BCAT1 links BCAA catabolism to HIF1α stability and regulation of the epigenomic landscape, mimicking the effects of IDH mutations. Our results suggest the BCAA-BCAT1-αKG pathway as a therapeutic target to compromise leukaemia stem-cell function in patients with IDHTET2 AML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nature24294 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of common core genes and pathways in childhood sepsis and cancer by bioinformatics analysis.
Discov Oncol
December 2024
Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Introduction: Sepsis and cancer are both leading causes of death worldwide, and they share several pathophysiological characteristics. Some studies have suggested a possible association between sepsis and cancer; however, few have investigated the core genes involved in both diseases.
Methods: Core genes common to both sepsis and cancer were identified using pediatric sepsis datasets (GEO: GSE26378, GSE4607, GSE8121 and GSE13904) and cancer databases (TCGA: BRCA, COADREAD, ESCA, KIRC, LIHC, LUAD, STAD).
Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.
Leukemia
November 2024
Departments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
Transcriptomics of Subcutaneous Tissue of Lipedema Identified Differentially Expressed Genes Involved in Adipogenesis, Inflammation, and Pain.
Plast Reconstr Surg Glob Open
November 2024
From the University of Luebeck, Luebeck, Germany.
Article Synopsis
- Lipedema is a painful fat distribution disorder primarily affecting women, and its causes are thought to involve issues with fat cell development, inflammation, and changes in connective tissue.
- A study analyzed the gene expression in subcutaneous tissue from different stages of lipedema, identifying genes linked to fat cell formation, lipid accumulation, inflammation, and pain sensitivity.
- The research indicates that the mechanisms behind lipedema involve unique changes compared to regular fat tissue, influencing its development and resulting in the disease's symptoms.
Small-molecule targeting BCAT1-mediated BCAA metabolism inhibits the activation of SHOC2-RAS-ERK to induce apoptosis of Triple-negative breast cancer cells.
J Adv Res
October 2024
Department of Critical Care Medicine, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, 518020, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Center for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou, 510006, China; State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China. Electronic address:
Article Synopsis
- Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer with poor outcomes, prompting research into new carcinogenic factors and therapies.
- This study investigates Eupalinolide B (EB), a natural compound with anti-cancer properties, focusing on how it targets BCAT1, an enzyme involved in amino acid metabolism that is linked to TNBC progression.
- Findings reveal that EB effectively inhibits TNBC by targeting BCAT1, disrupting BCAA metabolism and the SHOC2-RAS-ERK signaling pathway, which leads to increased apoptosis of TNBC cells.
Article Synopsis
- The study examines the consistency of differentially expressed genes (DEGs) in Alzheimer's Disease (AD), Parkinson's Disease (PD), and COVID-19 by analyzing multiple published datasets.
- It finds that while DEGs in PD and COVID-19 datasets can reasonably predict case status in other studies, DEGs in AD datasets perform poorly on this front.
- A new meta-analysis method (SumRank) was developed, enhancing predictive power by integrating DEGs across datasets and resulting in the identification of both known and new biological pathways related to these diseases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!